BAXTER INTERNATIONAL INC. Increase (Decrease) in Accounts Payable
BAXTER INTERNATIONAL INC. (BAX) reported Increase (Decrease) in Accounts Payable of $50.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-30
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$52.00M, a 1140.00% decline year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $102.00M, a 537.50% increase year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $39.00M, a 64.22% decline year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$57.00M, a 812.50% decline year-over-year.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for fiscal 2025 was $3.00M, a 97.32% decline from fiscal 2024.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for fiscal 2024 was $112.00M, a 21.74% increase from fiscal 2023.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for fiscal 2023 was $92.00M.
- BAXTER INTERNATIONAL INC. increase (decrease) in accounts payable for fiscal 2022 was -$67.00M, a 163.81% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$52.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $50.00M 10-Q · filed 2026-07-30 | $89.00M derived: sum of 3 quarters · filed 2026-07-30 | $32.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $102.00M 10-Q · filed 2026-04-30 | $141.00M derived: sum of 2 quarters · filed 2026-04-30 | $84.00M derived: sum of 3 quarters · filed 2026-04-30 | $89.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$18.00M derived: sum of 2 quarters · filed 2026-02-12 | -$13.00M derived: sum of 3 quarters · filed 2026-07-30 | $3.00M 10-K · filed 2026-02-12 | ||||
| 2025-09-30 | -$57.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$52.00M derived: sum of 2 quarters · filed 2026-07-30 | -$36.00M 10-Q · filed 2025-11-04 | $73.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $21.00M 10-Q · filed 2026-07-30 | $130.00M derived: sum of 3 quarters · filed 2026-07-30 | $138.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $16.00M 10-Q · filed 2026-04-30 | $125.00M derived: sum of 2 quarters · filed 2026-04-30 | $133.00M derived: sum of 3 quarters · filed 2026-04-30 | $9.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | $109.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $117.00M derived: sum of 2 quarters · filed 2026-02-12 | -$7.00M derived: sum of 3 quarters · filed 2026-02-12 | $112.00M 10-K · filed 2026-02-12 | ||||
| 2024-09-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$116.00M derived: sum of 2 quarters · filed 2025-11-04 | $3.00M 10-Q · filed 2025-11-04 | -$66.00M derived: sum of 4 quarters · filed 2026-02-12 | ||||
| 2024-06-30 | -$124.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$5.00M 10-Q · filed 2025-08-05 | $64.00M 10-Q · filed 2024-08-06 | -$74.00M derived: sum of 3 quarters · filed 2026-02-12 | -$70.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-03-31 | $119.00M 10-Q · filed 2025-05-06 | $131.00M 10-Q · filed 2024-05-02 | $50.00M derived: sum of 2 quarters · filed 2026-02-12 | $54.00M derived: sum of 3 quarters · filed 2026-02-12 | $67.00M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2023-12-31 | -$69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$65.00M derived: sum of 2 quarters · filed 2026-02-12 | -$52.00M derived: sum of 3 quarters · filed 2026-02-12 | $92.00M 10-K · filed 2026-02-12 | $107.00M 10-K · filed 2024-02-08 | |||
| 2023-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $17.00M derived: sum of 2 quarters · filed 2024-11-12 | $161.00M 10-Q · filed 2024-11-12 | $136.00M 10-Q · filed 2023-11-02 | $13.00M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-06-30 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $157.00M 10-Q · filed 2024-08-06 | $9.00M derived: sum of 3 quarters · filed 2025-02-21 | $4.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | $144.00M 10-Q · filed 2024-05-02 | $157.00M 10-Q · filed 2023-04-27 | -$4.00M derived: sum of 2 quarters · filed 2025-02-21 | -$9.00M derived: sum of 3 quarters · filed 2025-02-21 | $72.00M derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | -$148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$153.00M derived: sum of 2 quarters · filed 2025-02-21 | -$72.00M derived: sum of 3 quarters · filed 2025-02-21 | -$67.00M 10-K · filed 2025-02-21 | -$76.00M 10-K · filed 2023-02-09 | |||
| 2022-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $76.00M derived: sum of 2 quarters · filed 2023-11-02 | $81.00M 10-Q · filed 2023-11-02 | $84.00M 10-Q · filed 2022-10-27 | $172.00M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-06-30 | $81.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $86.00M 10-Q · filed 2023-07-27 | $91.00M 10-Q · filed 2022-07-28 | $177.00M derived: sum of 3 quarters · filed 2024-02-08 | $200.00M derived: sum of 4 quarters · filed 2024-02-08 | |||
| 2022-03-31 | $5.00M 10-Q · filed 2023-04-27 | $96.00M derived: sum of 2 quarters · filed 2024-02-08 | $119.00M derived: sum of 3 quarters · filed 2024-02-08 | $88.00M derived: sum of 4 quarters · filed 2024-02-08 | ||||
| 2021-12-31 | $91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $114.00M derived: sum of 2 quarters · filed 2024-02-08 | $83.00M derived: sum of 3 quarters · filed 2024-02-08 | $105.00M 10-K · filed 2024-02-08 | $104.00M 10-K · filed 2022-02-23 | |||
| 2021-09-30 | $23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$8.00M derived: sum of 2 quarters · filed 2022-10-27 | $14.00M 10-Q · filed 2022-10-27 | $99.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | -$31.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28 | -$9.00M 10-Q · filed 2022-07-28 | $76.00M derived: sum of 3 quarters · filed 2023-02-09 | -$68.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | $22.00M 10-Q · filed 2022-04-28 | $107.00M derived: sum of 2 quarters · filed 2023-02-09 | -$37.00M derived: sum of 3 quarters · filed 2023-02-09 | -$3.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$59.00M derived: sum of 2 quarters · filed 2023-02-09 | -$25.00M derived: sum of 3 quarters · filed 2023-02-09 | $57.00M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | -$144.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$110.00M derived: sum of 2 quarters · filed 2021-10-28 | -$28.00M 10-Q · filed 2021-10-28 | |||||
| 2020-06-30 | $34.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $116.00M 10-Q · filed 2021-07-29 | ||||||
| 2020-03-31 | $82.00M 10-Q · filed 2021-04-29 | |||||||
| 2019-12-31 | -$23.00M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |